Pliva, Others Escape Generic Reglan Suit Due To Mensing

Law360, New York (August 29, 2012, 3:23 PM EDT) -- Pliva Inc. and two other generic-drug makers have won the dismissal of a suit in Louisiana federal court that claimed a woman's movement disorder was caused by generic Reglan, ruling design defect and other allegations are preempted by the U.S. Supreme Court decision in Pliva Inc. v. Mensing.

Plaintiff Mildred Jacobsen claimed metoclopramide manufactured by Pliva, Actavis Inc., an Actavis subsidiary, and Northstar Rx LLC caused her tardive dyskinesia. Metaclopramide is the generic form of the diabetes medication Reglan.

The companies failed to adequately warn of...
To view the full article, register now.




Case Information

Case Title

Jacobsen v. Wyeth LLC et al

Case Number



Louisiana Eastern

Nature of Suit

Personal Inj. Prod. Liability


Nannette Jolivette Brown

Date Filed

March 8, 2010

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.